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Kao et al. have reported in Critical Care the histological
findings of 101 patients with acute respiratory distress
syndrome (ARDS) undergoing open lung biopsy. Diffuse
alveolar damage (DAD), the histological hallmark
of ARDS, was present in only 56.4 % of cases. The
presence of DAD was associated with higher mortality.
Evidence from this and other studies indicates that the
clinical criteria for the diagnosis of ARDS identify DAD in
only about half of the cases. On the contrary, there is
evidence that the clinical course and outcome of ARDS
differs in patients with DAD and in patients without
DAD. The discovery of biomarkers for the physiological
(increased alveolocapillary permeability) or histological
(DAD) hallmarks of ARDS is thus of paramount
importance.ging from 13 to 58 % in studies using OLB [2–5, 9, 10]Kao et al. [1] have made an important contribution to
the knowledge of the histological changes associated
with acute respiratory distress syndrome (ARDS) and
the potential role of open lung biopsy (OLB) in the diag-
nosis and management of ARDS. The authors studied
the histological findings in OLB from 101 patients with
a diagnosis of ARDS over 15 years. Indications for OLB
included a suspicion of noninfectious cause that could
benefit from corticosteroid treatment. Notwithstanding
the obvious selection bias, histological information from
OLB or autopsy tissue samples is of cardinal importance
for a better understanding of the pathogenesis and man-
agement of ARDS. Kao et al.’s [1] main findings are that
diffuse alveolar damage (DAD) was present in only* Correspondence: aesteban@ucigetafe.com
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DAD was associated with a worse outcome in patients
with ARDS. The results of OLB, in accordance with
other studies [2–5], changed management in a substan-
tial proportion of patients.
ARDS is a syndrome of acute respiratory failure due to
pulmonary inflammation developing after a known risk
factor, leading to increased endothelial and epithelial
permeability, pulmonary edema, hypoxemia, loss of aer-
ated tissue, decreased lung compliance, and bilateral
opacities in the chest X-ray image. The histological
correlate of ARDS is DAD, characterized by lung edema,
inflammation, hemorrhage, hyaline membranes, and al-
veolar epithelial cell injury [6–8].
The agreement between the clinical diagnosis of ARDS
according to commonly accepted criteria [7, 8] and the
presence of DAD at histological examination is poor, ran-
and from 45 to 88 % in autopsy studies [11–16]. In two
autopsy studies using the Berlin definition of ARDS [8],
DAD was present in only 45 % of patients diagnosed with
ARDS [11, 12].
Conditions identified in patients without DAD include,
among others, organizing pneumonia, eosinophilic pneu-
monia, pulmonary embolism, drug-induced pneumonitis,
alveolar hemorrhage, lymphangitis, malignancy, or vascu-
litis. Of note, in one study [12] 14 % of patients with
ARDS did not have pathological changes, probably repre-
senting cases with diffuse atelectasis that appear clinically
as ARDS but resolve as the lungs are inflated at high pres-
sure prior to fixation.
Many of the conditions identified at the histological
examination do not share the same pathogenesis, treat-
ment, and biomarkers as DAD. The failure of previous
studies into the treatment of ARDS has thus been attrib-
uted in part to a lack of a reliable definition of ARDS
designating a homogeneous phenotype.
The importance of identifying a homogeneous pheno-
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with DAD and in patients without DAD (71.9 % versus
41.5 %). In a recent study, Guerin et al. [9] reported in
83 patients with ARDS undergoing OLB a higher airway
plateau pressure, worse oxygenation, and (not reaching
statistical significance) higher mortality in patients with
DAD versus patients without DAD. These findings [1, 9]
together suggest that the histological finding of DAD
defines a specific population of patients within the syn-
drome of ARDS.
The heterogeneity of conditions designated with the
same clinical diagnostic criteria as well as data suggest-
ing that the clinical course differs in patients with DAD
and in patients without DAD thus underline the import-
ance of identifying patients with specific clinicopatholog-
ical phenotypes within those diagnosed with ARDS.
Another challenge for our understanding of ARDS is
the identification of the mechanisms explaining why
some patients with a clinical risk factor go on to develop
ARDS whereas others do not. Hopefully, the recognition
of these patients at risk should be accomplished early in
their course, before the requirement of ventilatory sup-
port. Biomarkers should thus be determined in the blood
rather than in bronchoalveloar lavage fluid.
In conclusion, after almost five decades of research [6],
ARDS continues to pose challenges for physicians and
scientists. The discovery of markers for the physiological
(e.g., alveolocapillary hyperpermeability) or histological
(hyaline membrane) hallmarks of ARDS is of great im-
port for the identification of a specific phenotype within
ARDS.
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